MissionIRNewsBreaks – Nextech AR Solutions Corp.’s (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29) EdTechX Enabling Valuable Digital Learning Experiences

 Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a provider of virtual and augmented reality (“AR”) experience technologies and services for e-commerce, education, advertising, conferences, and events, recently launched EdTechX. EdTechX is a global higher education solution built on Microsoft Azure and available on Nextech’s LiveX Digital Experience Platform (“DXP”). According to a recent article, EdTechX enables education institutions “to move with the times by transforming traditional learning and event formats into valuable digital experiences.” The solution solves problems previously linked to virtual learning, including the inability to reproduce the sort of instructor-student engagement present in the class environment and the shortcomings of software for conference calls, which cannot provide a personalized experience nor handle large classes. The article quoted Nancy Teodoro, education partner lead at Microsoft (NASDAQ: MSFT) Canada, as saying, “Nextech AR Solutions is helping education institutions digitally transform the way educators teach and the way students learn by enabling remote experiential learning through EdTechX.”

To view the full article, visit https://ibn.fm/PdZic

About Nextech AR Solutions Corp.

Nextech develops and operates augmented reality (“AR”) platforms that transport three-dimensional (“3D”) product visualizations, human holograms and 360° portals to its audiences, altering e-commerce, digital advertising, hybrid virtual events (events held in a digital format blended with in-person attendance) and learning and training experiences. Nextech focuses on developing AR solutions; however, most of the company’s revenues are derived from three e-commerce platforms, VacuumCleanerMarket.com (“VCM”), InfinitePetLife.com (“IPL”) and TruLyfeSupplements.com (“TruLyfe”), as well as VCM and product sales of residential vacuums, supplies, and parts, and small home appliances sold on Amazon. For more information about the company, visit www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Making Strides to Restore Critical US Rare Earth Supply Chains

 Energy Fuels (NYSE American: UUUU) (TSX: EFR) continues to focus on its efforts to produce commercial rare earth elements (“REEs”) as well as on uranium production as the U.S. government looks to support moves to limit dependence on other countries for the mining and production of various metals. “Without a doubt, Energy Fuels is making major strides toward restoring critical U.S. rare earth supply chains while also maintaining our position as the leading U.S. uranium producer,” said UUUU’s president and CEO Mark S. Chalmers in a recent update. “On rare earths, our efforts over the past several months culminated in the announcement on March 1 that Energy Fuels and Neo Performance Materials were creating a new, U.S.-European rare earth supply chain. In early March, we began to receive shipments of rare-earth-rich natural monazite sands from Chemours’ Georgia heavy mineral sand operations. In late-March, we began to ramp-up production of an intermediate rare earth product at our White Mesa Mill in Utah using monazite from Chemours. This is expected to be a high-value product ready to be separated and refined into value-added rare earth products at Neo’s plant in Europe. At this time, no other U.S. company is producing a product this far down the rare earth value chain.”

To view the full article, visit https://ibn.fm/W3WfB

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant, and is in the process of ramping up to expected commercial production of REE carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of over 8 million pounds of U3O8 per year and has the ability to produce vanadium when market conditions warrant, as well as REE carbonate and uranium from monazite. The Nichols Ranch ISR Project is currently on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also currently on standby. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. The primary trading market for Energy Fuels’ common shares is the NYSE American under the trading symbol “UUUU,” and the company’s common shares are also listed on the Toronto Stock Exchange under the trading symbol “EFR.” For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Positioned for Success in 2021 and Beyond

 HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leader in the health and wellness cannabidiol (“CBD”) industry, is keen on expanding its international distribution channels, demonstrating its compliance with regulatory standards for hemp-derived products worldwide, and seeking to expand access points for CBD. The company’s HempFusion USA, through Probulin Probiotics LLC, sells its products in about 4,000 retail locations in all 50 U.S. States. “Probulin’s network for probiotics sales has proved useful for helping the company gain an entry point in marketplaces hesitant to consider CBD,” reads a recent article. In March, the company announced Probulin’s entry into the Asian market through Tmall Global and, in April, announced its products had received Tmall’s conditional approval. HempFusion also sells its Probulin products in Mexico, South Korea, the United Arab Emirates, and Ireland with expectations of entering India and the United Kingdom. According to an April operational update by the company, “COVID and continued lack of clarity from the FDA related to official regulatory guidance for CBD used in dietary supplements, foods and beverages has made 2020 a challenging year. However, these challenges have led to strategic changes, establishing the foundation for HempFusion to succeed in 2021 and beyond.”

To view the full article, visit https://ibn.fm/qyc1j

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 US states and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs, including tinctures, proprietary FDA Drug-listed over-the-counter (“OTC”) topicals, doctor/practitioner lines, and more. With a strong focus on R&D, HempFusion has an additional 30 products under development. HempFusion is a board member of the U.S. Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in-store or by visiting HempFusion online at www.Hempfusion.com or www.Probulin.com.

NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://ibn.fm/CBDHF 

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Leading the Independent Pack, Poised in Market Projected to Hit $1B

 The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) achieved $41.1 million in revenue for fiscal year 2020, representing a 28% year-over-year increase as reflected in its most recent financial report. Now the largest independent alkaline water company in the nation, the company’s accomplishment to lead the pack is impressive and positions it well as the market is projected to reach $1 billion in 2022 (https://ibn.fm/lMRiX). “WTER has shown consistent growth since the release of its flagship product: Alkaline88(R). Alkaline88 ionized water contains only two ingredients — water and Pink Himalayan rock salt — and has built a reputation for superior hydration with a perfect 8.8 pH balance. The brand was formulated to offer a smooth taste that encourages consumers to drink more and fully hydrate, key factors in maintaining health and wellness,” reads a recent article. “Alkaline88 is now available in more than 75,000 retail stores nationwide, and in addition to being number one in the indie alkaline water space, the brand has captured a prestigious spot as one of the top-10 largest enhanced water brands in the country as well. As per Nielsen data, the brand is the only top-10, nonflavored, value-added water brand that has consistently grown double digits in both units and dollar volume every four-week period since the end of 2019. In addition, research indicates that Alkaline88 has the greatest brand loyalty among alkaline water drinkers.”

To view the full article, visit https://ibn.fm/46pa5

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique, all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products Inc. includes the company’s lab-tested, hemp-extract salves, balms, lotions, essential oils, bath salts, powder packs, oil tinctures, capsules, and gummies. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER   

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Receives FDA Fast Track Status for Berubicin Study

 CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, announced that the U.S. Food and Drug Administration granted Fast Track Designation for Berubicin, the company’s lead investigational drug. The status was received for the company’s evaluation of Berubicin for the treatment of patients with recurrent glioblastoma multiforme (“GBM”). An anthracycline, Berubicin falls in a class of anticancer agents that are among the most powerful chemotherapy drugs, proven to be effective against more types of cancer than any other category of chemotherapeutic agents. Fast Track Designation provides opportunities to expedite the development and review process for drugs intended to treat serious or life-threatening conditions when those drugs show potential to address unmet medical need. CNS has already begun patient enrollment in its upcoming study of Berubicin for the treatment of recurrent glioblastoma multiforme. “Receiving Fast Track Designation from the U.S. FDA is a huge achievement in our advancement of Berubicin for the treatment of glioblastoma, the most aggressive, deadly and treatment-resistant type of cancer that forms in the brain,” said CNS Pharmaceuticals CEO John Climaco in the press release. “If there were ever a disease where the unmet clinical need demands action, it is GBM. Patients have almost no meaningful options, and thousands lose their fight against this terrible cancer every year. With this designation, we now have an accelerated pathway to approval for Berubicin and a clear opportunity to more expediently bring this potentially impactful investigational therapy to individuals battling this challenging disease.”

To view the full press release, visit https://ibn.fm/u83EB

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme, an aggressive and incurable form of brain cancer.

Additionally, CNS Pharmaceuticals is advancing the development of its WP1244 drug technology, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents and is believed to be 500 times more potent than daunorubicin in inhibiting tumor cell proliferation. Preclinical studies of WP1244 demonstrated high uptake in the brain with antitumor activity. CNS Pharmaceuticals is evaluating the use of WP1244 in the treatment of brain, pancreatic and ovarian cancers as well as lymphomas. For more information about the company, please visit www.CNSPharma.com

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Issues Statement on Continued Commitment to High Compliance Standards in ENDS Industry

 Kaival Brands (OTCQB: KAVL) is the exclusive global distributor of products manufactured by Bidi Vapor LLC, including the BIDI(R) Stick disposable electronic nicotine delivery system (“ENDS”), intended exclusively for adults 21 and over. Kaival Brands today issued a statement prioritizing its compliance with the Tobacco Control Act and the PACT Act. “First and foremost, our chief concern and priority is continuing to prevent youth access to Bidi Vapor products,” said Kaival Brands CEO Niraj “Raj” Patel in the press release. “We are parents and run our company with youth prevention as a priority. These increased precautions add levels of protection that not only help prevent our products from reaching minors, but also protect adult consumers from potentially dangerous and hazardous counterfeit products. As partners, Bidi Vapor and Kaival Brands spare no expense to go above and beyond the stringent regulatory requirements. However, with the current state of limited enforcement, it does make being one of the few companies playing by the rules challenging. Nonetheless, we will continue to hold ourselves to our own high compliance standards and will continue to be a leader for the ENDS industry, because it is the right thing to do.”

To view the full press release, visit https://ibn.fm/ConyF

About Kaival Brands Innovations Group Inc.

Based in Grant, Florida, Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. The company’s vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. Kaival Brands is the exclusive global distributor of all products manufactured by Bidi Vapor LLC. For more information about the company, visit www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Launches High Times Branded Vapes Throughout Michigan

 Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced the successful launch of High Times branded vapes into the Michigan market. Building on RWB’s partnerships and the successful launch of High Times branded packaged flower and pre-rolls earlier in the year, the company is pleased to introduce the High Times branded vapes, offered as premium live resin and distillate cartridges. The High Times branded vapes and previously launched products are available at 22 of Michigan’s finest dispensaries, while the High Times branded product portfolio will be made available to a significant number of the 250+ dispensaries in the state in the second half of 2021. “As I’ve stated before, we look forward to bringing exceptional quality, price and experience through our house of brands and product lines to loyal consumers in Michigan,” said Brad Rogers, RWB’s chairman and CEO. “We have been able to utilize partnerships in Michigan to establish branded product sales and are currently in the final steps of establishing our own operations in Michigan to allow us to utilize all that we have learned and leverage the investments we have made to accelerate that growth.”

To view the full press release, visit https://ibn.fm/Iyixt

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Florida, California, Oklahoma, Arizona, and Massachusetts with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Infobird Co., Ltd. (NASDAQ: IFBD) Digitally Transforming Companies in the Retail Industry

 

• Infobird is committed to digitally transforming businesses and whole industries by offering robust customer engagement solutions that embody the crucial aspects of digital transformation
• These aspects, enumerated by Deloitte China, include: digital, analytics, cloud, cybersecurity, and regulatory compliance
• Two retail companies have selected IFBD’s solutions in less than a month
• The collaboration with Zu Li Jian has set up a new path for the digital transformation of retail companies

Evolving customer expectations and business needs have fueled a digital transformation in China, marked by the integration of cloud computing and artificial intelligence (“AI”) into companies’ operations. 

“To survive in this new world, businesses must learn to observe, think, and operate differently,” reads Deloitte China’s webpage about digital transformation (https://ibn.fm/nPTXa). “Digital transformation, the cross-disciplinary power comprising digital, analytics, cloud, cybersecurity, and regulatory compliance, is about embracing digital disruption and unlocking exponential value.”

Interestingly, Infobird Software (NASDAQ: IFBD), a Software-as-a-Service (SaaS) company offering AI-enabled end-to-end customer engagement solutions in China, has packaged the aspects of digital transformation mentioned above, i.e., cloud computing, analytics, cybersecurity, and digital, into its robust proprietary solutions and is using them to help companies around China adapt to the changing times and transform digitally. 

IFBD’s customer engagement solutions, which integrate the needs of both the customers and the businesses into a single platform, stimulate companies’ market performance and growth and enable them to improve their infrastructure. The platform uses big data and AI to analyze data from multiple channels and subsequently create portraits representing each user, plus their expectations and needs. 

The platform’s capabilities enable companies to understand their customers more comprehensively and accurately, creating a foundation for precision marketing in e-commerce and physical stores. It is no wonder that IFBD is increasingly witnessing success within the retail industry.

A company that leveraged its experience in the finance industry to enter other industries and, as a result, grow its standardized SaaS platform, Infobird has already worked with a leading Chinese multinational technology company specializing in e-commerce and retail. Notably, IFBD appears to be experiencing even more success within this sector. 

Just recently, Zu Li Jian, the leading shoe company for the elderly in China, selected IFBD’s solutions (https://ibn.fm/WMzM8) less than a month after SaSa Cosmetics (China) Co. Ltd. (https://ibn.fm/oVeFr) entered into a similar cooperative agreement with IFBD. Per both agreements, IFBD’s solutions are intended to digitally improve and optimize the retail companies’ marketing, management, and customer service.

The partnership between IFBD and Zu Li Jian, in particular, has set up a new path for the digital transformation of retail companies. This aligns with IFBD’s commitment to continually contribute to the development of more industries and companies. Further, the cooperation promotes the deployment of AI-based SaaS within the retail sector.  

Infobird, which is keen on capturing the Chinese SaaS market share, is increasingly making strides towards attaining this target, all while digitally transforming companies within the retail industry, as well as other industries.

For more information, visit the company’s website at www.Infobird.com/en/index.html.

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://ibn.fm/IFBD 

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html